Fairscale Capital, LLC

Position in CTXR — Citius Pharmaceuticals, Inc.

CIK 2032350 NASHUA, NH

Position in CTXR

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$25

-$12 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 43 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fairscale Capital, LLC holds $8,514 across 5 Biotechnology names. CTXR ranks #5 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	37	$3,944
2	CRSP	CRISPR Therapeutics AG	59	$3,217
3	MRNA	Moderna, Inc.	14	$980
4	FTRE	Fortrea Holdings Inc.	20	$348
5	CTXR	Citius Pharmaceuticals, Inc. This page	42	$25

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25	42	0.0%	Shares	Sole	2026-08-07
2026-03-31	$37	42	0.0%	Shares	Sole	2026-05-11
2025-12-31	$32	42	0.0%	Shares	Sole	2026-02-17
2025-09-30	$52	42	0.0%	Shares	Sole	2025-11-06
2025-06-30	$66	42	0.0%	Shares	Sole	2025-08-12
2025-03-31	$62	42	-88.5%	Shares	Sole	2025-05-14
2024-12-31	$1,464	366	-96.0%	Shares	Sole	2025-02-07
2024-09-30	$4,586	9,155	0.0%	Shares	Sole	2024-11-12
2024-06-30	$5,346	9,155	—	Shares	Sole	2024-08-13
No filing history on record for this holder in this stock.